These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 21336512)
1. Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection. Zhang XF; Lai EC; Kang XY; Qian HH; Zhou YM; Shi LH; Shen F; Yang YF; Zhang Y; Lau WY; Wu MC; Yin ZF Ann Surg Oncol; 2011 Aug; 18(8):2218-23. PubMed ID: 21336512 [TBL] [Abstract][Full Text] [Related]
2. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma. Hayashi K; Kumada T; Nakano S; Takeda I; Sugiyama K; Kiriyama S; Sone Y; Miyata A; Shimizu H; Satomura S Am J Gastroenterol; 1999 Oct; 94(10):3028-33. PubMed ID: 10520864 [TBL] [Abstract][Full Text] [Related]
3. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma. Tada T; Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kitabatake S; Kuzuya T; Nonogaki K; Shimizu J; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J; Satomura S Liver Int; 2005 Aug; 25(4):848-53. PubMed ID: 15998436 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC. Toyoda H; Kumada T; Kaneoka Y; Osaki Y; Kimura T; Arimoto A; Oka H; Yamazaki O; Manabe T; Urano F; Chung H; Kudo M; Matsunaga T J Hepatol; 2008 Aug; 49(2):223-32. PubMed ID: 18571271 [TBL] [Abstract][Full Text] [Related]
5. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma. Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571 [TBL] [Abstract][Full Text] [Related]
6. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Tateishi R; Shiina S; Yoshida H; Teratani T; Obi S; Yamashiki N; Yoshida H; Akamatsu M; Kawabe T; Omata M Hepatology; 2006 Dec; 44(6):1518-27. PubMed ID: 17133456 [TBL] [Abstract][Full Text] [Related]
7. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease. Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252 [TBL] [Abstract][Full Text] [Related]
8. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis? Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381 [TBL] [Abstract][Full Text] [Related]
9. Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL. Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A; Kanke F; Satomura S Cancer Sci; 2011 May; 102(5):1025-31. PubMed ID: 21244578 [TBL] [Abstract][Full Text] [Related]
10. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy. Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841 [TBL] [Abstract][Full Text] [Related]
11. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis. Shim JH; Yoon DL; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS Ann Surg Oncol; 2012 Nov; 19(12):3687-96. PubMed ID: 22644512 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma. Yoshida S; Kurokohchi K; Arima K; Masaki T; Hosomi N; Funaki T; Murota M; Kita Y; Watanabe S; Kuriyama S Int J Oncol; 2002 Feb; 20(2):305-9. PubMed ID: 11788893 [TBL] [Abstract][Full Text] [Related]
13. Clinical utility of lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a Thai referral population. Tanwandee T; Setthasin S; Charatcharoenwitthaya P; Chainuvati S; Leelakusolvong S; Pausawasdi N; Srikureja W; Pongprasobchai S; Manatsathit S; Kachintorn U; Ekpo P; Senawong S J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S49-56. PubMed ID: 19562986 [TBL] [Abstract][Full Text] [Related]
14. [The studies on early warning of Lens culinaris-reactive alpha-Fetoprotein (AFP-L3) detecting in primary hepatocellular carcinoma]. Li YL; Ma HB; Guo JX; Shi JB; Xu J; Liu AX; Yang LH; Li BA; Mao YL Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):336-8. PubMed ID: 19469167 [TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Preoperative Hepatocellular Carcinoma With High Yamao T; Yamashita YI; Imai K; Umezaki N; Tsukamoto M; Kitano Y; Arima K; Miyata T; Nakagawa S; Okabe H; Hayashi H; Chikamoto A; Ishiko T; Baba H Anticancer Res; 2019 Feb; 39(2):883-889. PubMed ID: 30711971 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma. Hayashi M; Shimizu T; Hirokawa F; Inoue Y; Komeda K; Asakuma M; Miyamoto Y; Takeshita A; Shibayama Y; Tanigawa N Am Surg; 2011 May; 77(5):572-8. PubMed ID: 21679590 [TBL] [Abstract][Full Text] [Related]
17. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Sterling RK; Jeffers L; Gordon F; Venook AP; Reddy KR; Satomura S; Kanke F; Schwartz ME; Sherman M Clin Gastroenterol Hepatol; 2009 Jan; 7(1):104-13. PubMed ID: 18849011 [TBL] [Abstract][Full Text] [Related]
18. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma]. Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471 [TBL] [Abstract][Full Text] [Related]
19. Scoring system based on tumor markers and Child-Pugh classification for HCC patients who underwent liver resection. Nakagawa S; Hayashi H; Nitta H; Okabe H; Sakamoto K; Higashi T; Kuroki H; Imai K; Hashimoto D; Sakamoto Y; Chikamoto A; Beppu T; Baba H Anticancer Res; 2015 Apr; 35(4):2157-63. PubMed ID: 25862872 [TBL] [Abstract][Full Text] [Related]
20. Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance. Zhang XF; Yin ZF; Wang K; Zhang ZQ; Qian HH; Shi LH Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):618-23. PubMed ID: 23232633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]